PROVIDE A NEW THERAPEUTIC STRATEGY USING OUR FIRST IN-CLASS DRUG TO REMODEL CHROMATIN TO FORCE GLIOMA STEM CELLS TO DIFFERENTIATE, THEREBY IMPROVING GLIOBLASTOMA CONTROL

Jennifer Yu, M.D., Ph.D.
Department of Cancer Biology and Department of Radiation Oncology
Cleveland Clinic

Liangqi Xie, PhD
Assistant Staff
Cleveland Clinic

Yogen Saunthararajah, MD
Professor
Cleveland Clinic